INVO Fertility Announces $4 Million Private Placement
ByAinvest
Tuesday, Dec 2, 2025 9:27 am ET1min read
IVF--
INVO Fertility has priced a $4.0 million private placement at-the-market under Nasdaq rules, selling 2,366,864 shares of common stock and warrants to purchase up to 4,733,728 shares. The offering is expected to close on December 3, 2025, subject to customary conditions. Maxim Group LLC is acting as the sole placement agent. The securities are being sold in a private placement under Section 4(a)(2) of the Securities Act, and the Company has agreed to file a registration statement for resale.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet